Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anxin Granules
- Development stage
- Unknown
- Lead developer
- Suzhou Yusen New Drug Development
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Anxin Granules is a Traditional Chinese Medicine (TCM) candidate developed by Suzhou Yusen New Drug Development for the treatment of premature ventricular contractions (PVCs). It is specifically indicated for patients with non-structural heart disease presenting with the TCM syndrome of 'Yin deficiency and fire hyperactivity.' The drug is currently in Phase II clinical development (e.g., trial CTR20240852), where it is being evaluated for its safety and efficacy in reducing the frequency of ventricular ectopy and alleviating associated symptoms. As a complex botanical formulation, its pharmacological profile likely involves the synergistic action of multiple herbal components to stabilize cardiac rhythm and restore autonomic balance, consistent with TCM principles of nourishing Yin and calming the heart.
- Brand names
- Anxin Granules
- Other names
- Anxin Keli
Beyond the preview
Go deeper on Anxin Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anxin Granules.